Rani Therapeutics director Imran Mir a buys $1.26 million in stock
PositiveFinancial Markets

Imran Mir, a director at Rani Therapeutics, has made a significant investment by purchasing $1.26 million in company stock. This move not only reflects his confidence in the company's future but also signals to investors that Rani Therapeutics is on a promising path. Such investments can boost market confidence and potentially lead to increased stock value, making it an important development for both the company and its shareholders.
— Curated by the World Pulse Now AI Editorial System












